SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Effective Collaboration - Team Research for Better Returns: -- Ignore unavailable to you. Want to Upgrade?


To: The Ox who wrote (1618)3/20/2013 12:22:12 PM
From: The Ox  Respond to of 8255
 
PHMD - similar stats to OMPI (before it's takeout).






To: The Ox who wrote (1618)3/20/2013 12:33:20 PM
From: richardred  Read Replies (1) | Respond to of 8255
 
I agree Ox. I see skin care as a hot area. All the biggies such as P & G (Olay), Unilever, Beiersdorf, J&J (Neutrogena) L'Oreal have all targeted skin care. I had MRX. I made out very well. I didn't hold through the takeout, but Sergio did.
Message 24374717
siliconinvestor.com
Message 28384442

Many years ago. I remember the stock pop in J & J when J & J came out with Retin-A. It helped reduce facial wrinkles. I think that some form of that compound is now in many over the counter facial skin care products. You have to ask yourself. What women wouldn't pay extra for wrinkle reduction.

PHMD looks interesting. I'm adding it to my watch list. I'm still holding Iconic AVP. It looks to be on a path to recovery. More time is needed for more certainty. I believe skin so soft and ANEW are their top selling skin care lines. L'orel is not looking for a direct seller. I've been watching Coty's moves since the failed bid. IMO Amway would still be interested today. (Nice Fit)
nytimes.com
avoncompany.com

Recent Laser deal also.
Cynosure Agrees to Buy Palomar in $294 Million Laser Deal

bloomberg.com